Pure Global AI
NCT06035939Not yet recruiting

SMYLS Multi-site Trial

Self-Management for Youth Living With Sickle Cell Disease: SMYLS Multi-site Trial
Medical University of South CarolinaClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Sickle Cell Disease
Drug/Device/Intervention
Voice Crisis Alert V2
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Medical University of South Carolina
Location
Charleston, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2023
End date
Jan 01, 2028
Enrollment
272 participants
Primary outcome

Self-management behaviors

Summary

The purpose of this study is to find out whether a web-based intervention using a mobile app
 is helpful for teens and young adults with sickle cell disease (SCD) in learning how to care
 for and manage their symptoms.

ICD-10 classifications
Sickle-cell disordersOther sickle-cell disordersSickle-cell traitSickle-cell anaemia with crisisSickle-cell anaemia without crisis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06035939
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06035939 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of South Carolina and is currently Not yet recruiting. The study focuses on Sickle Cell Disease. Target enrollment is 272 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.